Rilzabrutinib reduces itch and hives in patients with chronic spontaneous urticaria: JAMA
A new study published in the Journal of American Medical Association found that Rilzabrutinib decreased itching and hives while preserving a positive risk-benefit profile, indicating that it might be a useful therapy for individuals with moderate to severe chronic spontaneous urticaria (CSU) that is resistant to antihistamines. The primary cause of CSU is the activation […]